Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An atlas of common Salmonella serotypes from routinely notified human cases in the Northern Territory of Australia, 2005-2024.

Communicable diseases intelligence (2018)·2026
Same author

Hyperendemic Salmonellosis in the Northern Territory of Australia over a 20-Year Period, 2005-2024: An Epidemiological Analysis Using Routine Human Surveillance Data.

Foodborne pathogens and disease·2026
Same author

Measuring the excess mortality during the COVID-19 pandemic in the Northern Territory, Australia.

Epidemiology and infection·2026
Same author

The epidemiology of amoebiasis in the Northern Territory of Australia over 20 years (2005 - 2024).

Communicable diseases intelligence (2018)·2025
Same author

An outbreak of Salmonella Muenchen gastroenteritis after consuming wild hunted kangaroo, Northern Territory, Australia, 2024.

Communicable diseases intelligence (2018)·2025
Same author

Tuberculosis reactivation following apremilast therapy for psoriasis: Time to consider routine TB screening?

The Australasian journal of dermatology·2024

Related Experiment Video

Updated: Jul 4, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

Tuberculosis notifications in Australia, 2006.

Paul W Roche1, Vicki Krause, Anastasios Konstantinos

  • 1Surveillance Policy and Systems Section, Department of Health and Ageing, Canberra, Australian Capital Territory. paul.roche@health.gov.au

Communicable Diseases Intelligence Quarterly Report
|June 5, 2008
PubMed
Summary
This summary is machine-generated.

In 2006, Australia reported 1,201 tuberculosis (TB) cases, primarily among overseas-born individuals. High treatment success rates were observed, emphasizing ongoing TB awareness and control for elimination.

Related Experiment Videos

Last Updated: Jul 4, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

Area of Science:

  • Public Health
  • Infectious Disease Epidemiology
  • Communicable Disease Surveillance

Background:

  • The National Notifiable Disease Surveillance System monitors tuberculosis (TB) in Australia.
  • TB incidence has remained below 6 per 100,000 population since 1985.
  • Understanding TB epidemiology is crucial for public health strategies.

Purpose of the Study:

  • To report and analyze tuberculosis (TB) notifications in Australia for 2006.
  • To identify demographic trends and risk factors associated with TB.
  • To assess treatment outcomes and inform TB elimination strategies.

Main Methods:

  • Data extracted from the National Notifiable Disease Surveillance System for 2006.
  • Analysis of TB notifications, including new cases and relapses.
  • Calculation of incidence rates by population subgroup and risk factor identification.

Main Results:

  • 1,201 TB notifications in 2006; incidence was 5.8 per 100,000 population.
  • 85% of notifications were in people born outside Australia, with higher incidence in overseas-born (20.7/100,000) and Indigenous Australians (6.6/100,000).
  • Household contact was the most common risk factor; treatment success exceeded 95% for the 2005 cohort.

Conclusions:

  • Tuberculosis in Australia disproportionately affects overseas-born populations.
  • Maintaining high diagnostic and control standards, alongside global efforts, is vital for TB elimination.
  • Continued awareness and robust surveillance are necessary to achieve TB elimination goals.